Genetic immunization of neonates.
The vaccination of neonates is generally difficult due to immaturity of the immune system, higher susceptibility to tolerance and potential negative interference of maternal antibodies. Studies carried out in rodents and non-human primates showed that plasmid vaccines expressing microbial antigens, rather than inducing tolerance, triggered significant humoral and cellular immunity with a Th1 component. The ability of bacterial CpG motifs to activate immature antigen-presenting cells is critical for the neonatal immunogenicity of DNA vaccines. In addition, the endogenous production of antigen subsequent to transfection of antigen-presenting cells may explain the lack of inhibition by maternal antibodies of cellular responses. Together, these features make the plasmid vaccines an appealing strategy to prime immune responses against foreign pathogens, during early life. In combination with subsequent boosting using conventional vaccines, DNA vaccine-based regimens may provide a qualitatively superior immunity against microbes. Thorough understanding of immunomodulatory properties of plasmid-vectors may extend their use for early prophylaxis of inflammatory disorders.
Bot
Adrian
A
Department of Immunology, Alliance Pharmaceutical Corp., 6175 Lusk Blvd, San Diego, CA 92121, USA. axb@allp.com
Bona
Constantin
C
D000818:Animals; D001424:Bacterial Infections / Q000276:immunology / Q000517:prevention & control; D006801:Humans; D007112:Immunity, Maternally-Acquired / Q000276:immunology; D007156:Immunologic Memory; D007231:Infant, Newborn / Q000276:immunology*; D007232:Infant, Newborn, Diseases / Q000276:immunology* / Q000517:prevention & control; D014611:Vaccination; D019444:Vaccines, DNA / Q000276:immunology*
D019444:Vaccines, DNA